Background: Tigecycline is an antibiotic agent with a broad spectrum, which has an antibacterial effect against many multidrug-resistant organisms. However, its clinical efficacy in the treatment of hospital-acquired pneumonia (HAP) is disputed.
Materials And Methods: In this report, a systematic review and meta-analysis were conducted to evaluate the efficacy and safety of tigecycline for the treatment of HAP. The primary outcome was the rate of clinical cure, and the secondary outcomes were mortality and adverse events (AEs).
Results: Four trials involving 1,234 patients were included. The standard-dose tigecycline and comparator groups did not differ significantly in their rates of clinical cure. However, high-dose tigecycline was more effective than standard-dose tigecycline or the comparators for the treatment of HAP. There was no significant difference in mortality between the standard-dose or high-dose regimen and the comparators. Although the safety profile of standard-dose tigecycline was similar to the comparators, the high-dose regimen exhibited more AEs compared with the other groups.
Conclusion: High-dose tigecycline is efficient for the treatment of HAP but is associated with more AEs.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000445425 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Accelerated Aging Effect on the Stability of the 3D-Printed Biodegradable Implant for Bone Defect Repairs.
Materials (Basel)
December 2024
Institute of Security Technologies "MORATEX", 3 Marii Sklodowskiej-Curie Str., 90-505 Lodz, Poland.
This article presents an evaluation of the accelerated aging impact on the structural properties of biodegradable PLA/HAp implants produced using 3D printing technology for use in traumatic bone defect repairs in individual patients. The designed biodegradable implants were sterilized with a radiation dose of 25 ± 0.99% kGy, then exposed to an accelerated aging process.
View Article and Find Full Text PDFDevelopment of stable and porous AgO-loaded hydroxyapatite nanocomposites for enriched photocatalytic degradation of Rhodamine B under visible light.
Environ Sci Pollut Res Int
January 2025
Laboratory of Applied Chemistry of Materials, Faculty of Science, Mohammed V University in Rabat, Avenue Ibn Batouta BP.1014, Rabat, Morocco.
A simple and inexpensive process from natural phosphate in the presence of Ag ions was used to develop AgO-loaded hydroxyapatite nanocomposites. The structural and textural characterization of the nanocomposites suggests that the AgO nanoparticles are well dispersed on the hydroxyapatite (HAp). The prepared nanocomposites show efficient Rhodamine B (RhB) dye photocatalytic degradation in water under visible and UV-visible light irradiation.
View Article and Find Full Text PDFCo-application of hydrothermal carbonization aqueous phase and biogas slurry reduced ammonia volatilization in paddy.
J Environ Manage
January 2025
Key Laboratory of Agro-Environment in Downstream of Yangtze Plain, Ministry of Agriculture and Rural Affairs, Institute of Agricultural Resources and Environment, Jiangsu Academy of Agricultural Sciences, Nanjing, 210014, PR China.
Application of biogas slurry (BS) can promote ammonia (NH) volatilization. Algae sludge and Quercus acutissima leaves are rich in resources and nutrients, and can be effectively converted into valuable products. Hydrothermal carbonization technology (HTC) is a sustainable method for the treatment of wet biomass.
View Article and Find Full Text PDFImpact of Multidrug-Resistant Bacterial Colonization on Clinical Characteristics, Antibiotic Treatment, and Clinical Outcomes of Hospital-Acquired Pneumonia.
Lung
January 2025
Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Korea University Guro Hospital, 148, Gurodong-ro, Guro-gu, Seoul, 08308, Republic of Korea.
Purpose: To determine effects of colonization with multidrug-resistant bacteria (MDRB) in general wards on characteristics, treatment, and prognosis of hospital-acquired pneumonia (HAP).
Methods: This was a multicenter retrospective cohort study of patients with HAP admitted to 16 tertiary or university hospitals in Korea from July 2019 to December 2019. From the entire cohort, patients who developed pneumonia in general wards with known colonization status before the onset of pneumonia were included in this study.
Aerosolized plus intravenous polymyxin B in comparison to intravenous polymyxin B alone for the management of HAP caused by carbapenem-resistant gram-negative bacteria: a prospective multicenter cohort study.
Int J Antimicrob Agents
December 2024
Department of Critical Care Medicine, the Second Affiliated Hospital of Xi'an Jiaotong University, China. Electronic address:
Objectives: This study aimed to evaluate the clinical effectiveness of combined aerosolized (AER) and intravenous (IV) polymyxin B in managing patients with hospital-acquired pneumonia (HAP) caused by carbapenem-resistant gram-negative organism (CRO) .
Methods: This multicenter prospective cohort study was conducted across six intensive care units in municipal and above-municipal hospitals in Shaanxi, China, from January 1, 2021 to December 31, 2022. Patients with CRO pneumonia were categorized into the intravenous group (IV polymyxin B alone) and the combination group (AER plus IV polymyxin B).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!